Time as a Medical Force

This flow develops the theme that HCV outcomes are shaped by long latency, waiting-list delay, and the timing of intervention.

increasingBearing stren­gth in each eventdecreasing

Decades of Latency

Decades of Latency Slow accumulation Fibrosis, cirrhosis, and hepatocellular carcinoma may develop over decades. The patient often enters care after the infection has already reshaped the future. Delayed visibility Long latency separates cause from consequence. It also makes prevention difficult because a person can feel healthy while irreversible injury quietly accumulates.

Years on Dialysis

Years on Dialysis Waiting changes the patient Each year on dialysis adds cardiovascular burden, infection exposure, and the possibility of worsening liver disease. Time is not an empty interval between listing and transplantation. The clinical clock Surveillance and treatment timing become decisive. A patient’s eligibility, viral status, and operative risk may all change while an organ is still unavailable.

The Timing of Cure

The Timing of Cure Before is safer HCV eradication before transplantation avoids interferon-related graft rejection and may prevent posttransplant glomerulonephritis. The same therapy becomes more dangerous after graft implantation. Timing as treatment The book therefore treats when to intervene as part of what treatment means. A drug’s value depends on the biological state and institutional setting in which it is used.

from initial infection to chronic disease

during prolonged End-stage renal disease

before versus after Kidney transplantation